Heng Li

3.0k total citations
91 papers, 2.0k citations indexed

About

Heng Li is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Cancer Research. According to data from OpenAlex, Heng Li has authored 91 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Pulmonary and Respiratory Medicine, 30 papers in Molecular Biology and 22 papers in Cancer Research. Recurrent topics in Heng Li's work include Renal cell carcinoma treatment (13 papers), MicroRNA in disease regulation (10 papers) and Cancer-related molecular mechanisms research (10 papers). Heng Li is often cited by papers focused on Renal cell carcinoma treatment (13 papers), MicroRNA in disease regulation (10 papers) and Cancer-related molecular mechanisms research (10 papers). Heng Li collaborates with scholars based in China, United States and Macao. Heng Li's co-authors include Hua Xu, Zhangqun Ye, Yu Gan, Wei Xiao, Haibing Xiao, Kun Tang, Weimin Yao, Ke Chen, Bin Lang and Wei Guan and has published in prestigious journals such as PLoS ONE, Oncogene and Scientific Reports.

In The Last Decade

Heng Li

77 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Heng Li China 25 1.2k 936 315 284 185 91 2.0k
Yukio Naya Japan 31 1.5k 1.3× 1.3k 1.4× 868 2.8× 449 1.6× 282 1.5× 100 2.8k
Yongwei Yu China 26 1.0k 0.9× 488 0.5× 518 1.6× 179 0.6× 326 1.8× 79 1.7k
Andrew Borkowski United States 20 597 0.5× 244 0.3× 439 1.4× 177 0.6× 382 2.1× 39 1.5k
Roula Albadine United States 25 1.1k 1.0× 510 0.5× 1.2k 3.9× 391 1.4× 313 1.7× 51 2.1k
Francisco G. La Rosa United States 23 541 0.5× 286 0.3× 747 2.4× 491 1.7× 244 1.3× 88 2.2k
Roberta Mazzucchelli Italy 30 1.1k 0.9× 582 0.6× 1.2k 3.9× 800 2.8× 521 2.8× 145 2.9k
Patrick Flaherty United States 15 755 0.6× 209 0.2× 211 0.7× 336 1.2× 107 0.6× 34 1.7k
Zhuqing Jia China 25 879 0.7× 296 0.3× 89 0.3× 382 1.3× 123 0.7× 68 1.8k
Michael Bonham United States 12 1.3k 1.1× 324 0.3× 534 1.7× 108 0.4× 307 1.7× 16 2.0k
Tsung‐Lin Cheng Taiwan 24 651 0.6× 248 0.3× 133 0.4× 155 0.5× 130 0.7× 79 1.4k

Countries citing papers authored by Heng Li

Since Specialization
Citations

This map shows the geographic impact of Heng Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heng Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heng Li more than expected).

Fields of papers citing papers by Heng Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Heng Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heng Li. The network helps show where Heng Li may publish in the future.

Co-authorship network of co-authors of Heng Li

This figure shows the co-authorship network connecting the top 25 collaborators of Heng Li. A scholar is included among the top collaborators of Heng Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Heng Li. Heng Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Yu, Xiaoyu, Tingting Yang, Di Wu, et al.. (2025). PARP14 inhibits microglial activation via NNT to alleviate depressive-like behaviors in mice. Brain Behavior and Immunity. 126. 235–246. 1 indexed citations
3.
4.
Guo, Xiaotong, et al.. (2025). Single cell transcriptomic analysis reveals tumor immune infiltration by macrophage cells gene signature in lung adenocarcinoma. Discover Oncology. 16(1). 261–261. 1 indexed citations
5.
Fang, Qing, et al.. (2024). Reproductive factors, genetic susceptibility and risk of type 2 diabetes: A prospective cohort study. Diabetes & Metabolism. 50(5). 101560–101560. 6 indexed citations
6.
Kim, Jae Hyeon, Kyung-Hun Lee, Y.H. Park, et al.. (2024). Survival outcomes of young-age female patients with early breast cancer: an international multicenter cohort study. ESMO Open. 9(11). 103732–103732. 3 indexed citations
7.
8.
Li, Heng, et al.. (2024). Blockade of the deubiquitinating enzyme USP48 degrades oncogenic HMGA2 and inhibits colorectal cancer invasion and metastasis. Acta Pharmaceutica Sinica B. 14(4). 1624–1643. 9 indexed citations
9.
Yu, Xiaoyu, Zhenyu Fan, Tingting Yang, et al.. (2023). Plasma circRNA HIPK2 as a putative biomarker for the diagnosis and prediction of therapeutic effects in major depressive disorder. Clinica Chimica Acta. 552. 117694–117694. 7 indexed citations
10.
Wang, Haoxue, Yimin Cai, Meng Jin, et al.. (2023). Identification of specific susceptibility loci for the early-onset colorectal cancer. Genome Medicine. 15(1). 13–13. 7 indexed citations
11.
12.
13.
Li, Heng, et al.. (2019). Adversarial-Example Attacks Toward Android Malware Detection System. IEEE Systems Journal. 14(1). 653–656. 76 indexed citations
14.
Sun, Guoliang, Libin Yan, Wei Ouyang, et al.. (2019). Management for Ureteral Stenosis: A Comparison of Robot-Assisted Laparoscopic Ureteroureterostomy and Conventional Laparoscopic Ureteroureterostomy. Journal of Laparoendoscopic & Advanced Surgical Techniques. 29(9). 1111–1115. 17 indexed citations
15.
16.
Ohta, Hidenobu, et al.. (2017). Potential New Non-Invasive Therapy Using Artificial Oxygen Carriers for Pre-Eclampsia. Journal of Functional Biomaterials. 8(3). 32–32. 9 indexed citations
17.
Xiao, Haibing, Wei Xiao, Jing Cao, et al.. (2016). miR-206 functions as a novel cell cycle regulator and tumor suppressor in clear-cell renal cell carcinoma. Cancer Letters. 374(1). 107–116. 56 indexed citations
18.
Gan, Yu, Weimin Yao, Kiranmai Gumireddy, et al.. (2014). Pseudogene PTENP1 Functions as a Competing Endogenous RNA to Suppress Clear-Cell Renal Cell Carcinoma Progression. Molecular Cancer Therapeutics. 13(12). 3086–3097. 166 indexed citations
19.
Gan, Yu, Weimin Yao, Wei Xiao, et al.. (2014). MicroRNA-34a functions as an anti-metastatic microRNA and suppresses angiogenesis in bladder cancer by directly targeting CD44. Journal of Experimental & Clinical Cancer Research. 33(1). 779–779. 92 indexed citations
20.
Li, Heng. (2004). The credit risk of factoring service for commercial banks in our country and its countermeasures. Huadong jingji guanli.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yukio Naya Breakdown of academic impact, for papers by Yongwei Yu Breakdown of academic impact, for papers by Andrew Borkowski Breakdown of academic impact, for papers by Roula Albadine Breakdown of academic impact, for papers by Francisco G. La Rosa Breakdown of academic impact, for papers by Roberta Mazzucchelli Breakdown of academic impact, for papers by Patrick Flaherty Breakdown of academic impact, for papers by Zhuqing Jia Breakdown of academic impact, for papers by Michael Bonham Breakdown of academic impact, for papers by Tsung‐Lin Cheng
Rankless by CCL
2026